Novel Risk Factors for Central-Line Associated Bloodstream Infections in Critically Ill Children
Affiliations
- PMID: 31685049
- DOI: 10.1017/ice.2019.302
Abstract
Objective: Central-line-associated bloodstream infections (CLABSI) cause morbidity and mortality in critically ill children. We examined novel and/or modifiable risk factors for CLABSI to identify new potential targets for infection prevention strategies.
Methods: This single-center retrospective matched case-control study of pediatric intensive care unit (PICU) patients was conducted in a 60-bed PICU from April 1, 2013, to December 31, 2017. Case patients were in the PICU, had a central venous catheter (CVC), and developed a CLABSI. Control patients were in the PICU for ≥2 days, had a CVC for ≥3 days, and did not develop a CLABSI. Cases and controls were matched 1:4 on age, number of complex chronic conditions, and hospital length of stay.
Results: Overall, 72 CLABSIs were matched to 281 controls. Univariate analysis revealed 14 risk factors, and 4 remained significant in multivariable analysis: total number of central line accesses in the 3 days preceding CLABSI (80+ accesses: OR, 4.8; P = .01), acute behavioral health needs (OR, 3.2; P = .02), CVC duration >7 days (8-14 days: OR, 4.2; P = .01; 15-29 days: OR, 9.8; P < .01; 30-59 days: OR, 17.3; P < .01; 60-89 days: OR, 39.8; P < .01; 90+ days: OR, 4.9; P = .01), and hematologic/immunologic disease (OR, 1.5; P = .05).
Conclusions: Novel risk factors for CLABSI in PICU patients include acute behavioral health needs and >80 CVC accesses in the 3 days before CLABSI. Interventions focused on these factors may reduce CLABSIs in this high-risk population.
Similar articles
- Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.Intensive Care Med. 2017 Aug;43(8):1097-1104. doi: 10.1007/s00134-017-4852-7. Epub 2017 Jun 5.PMID: 28584925 Clinical Trial.
- Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.Acad Emerg Med. 2015 Sep;22(9):1048-55. doi: 10.1111/acem.12744.PMID: 26336036 Free PMC article. Clinical Trial.
- The influence of intensive care unit-acquired central line-associated bloodstream infection on in-hospital mortality: A single-center risk-adjusted analysis.Am J Infect Control. 2016 May 1;44(5):587-92. doi: 10.1016/j.ajic.2015.12.008. Epub 2016 Feb 10.PMID: 26874406 Clinical Trial.
- Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysis.BMJ Qual Saf. 2016 Aug;25(8):633-43. doi: 10.1136/bmjqs-2015-004450. Epub 2015 Nov 25.PMID: 26608456 Review.
- Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants.Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012181. doi: 10.1002/14651858.CD012181.pub2.PMID: 29512818 Free PMC article. Review.
No hay comentarios:
Publicar un comentario